Exact Mass: 591.108
Exact Mass Matches: 591.108
Found 23 metabolites which its exact mass value is equals to given mass value 591.108,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
UDP-2-acetamido-2,6-dideoxy-beta-L-talose
UDP-2-acetamido-2,6-dideoxy-beta-L-talose; UDP-N-acetyl-beta-L-pneumosamine
(E)-3-(6-Acetamidopyridin-3-yl)-N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide
(E)-3-(6-Acetamidopyridin-3-yl)-N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide
potassium 1-amino-4-[[3-[[(2-chloro-1-oxoallyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
potassium 1-amino-4-[[3-[[(2-chloro-1-oxoallyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
BX-795
N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
Uridine 5-(trihydrogen diphosphate) P-(6-azido-6-deoxy-alpha-D-glucopyranosyl) ester
Uridine 5-(trihydrogen diphosphate) P-(6-azido-6-deoxy-alpha-D-glucopyranosyl) ester
(E)-3-(6-Acetamidopyridin-3-yl)-N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide
(E)-3-(6-Acetamidopyridin-3-yl)-N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D065168 - Bradykinin Receptor Antagonists D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
1-[2-[3-Carboxy-5-[[3-carboxy-3-(2-carboxy-2-hydroxy-5-oxopyrrolidin-1-yl)propyl]amino]-3-hydroxy-5-oxopentanoyl]oxyethyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylic acid
1-[2-[3-Carboxy-5-[[3-carboxy-3-(2-carboxy-2-hydroxy-5-oxopyrrolidin-1-yl)propyl]amino]-3-hydroxy-5-oxopentanoyl]oxyethyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylic acid
[(2S,3S,4R,5S,6S)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate
[(2S,3S,4R,5S,6S)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate
GSK2033
GSK2033
GSK2033 is a LXR antagonist with pIC50s of 7 and 7.4 for LXRα or LXRβ, respectively.
1-{1-carboxy-3-[(3-carboxy-3-{2-[2-(2-carboxy-2-hydroxy-5-oxopyrrolidin-1-yl)ethoxy]-2-oxoethyl}-1,3-dihydroxypropylidene)amino]propyl}-2-hydroxy-5-oxopyrrolidine-2-carboxylic acid
1-{1-carboxy-3-[(3-carboxy-3-{2-[2-(2-carboxy-2-hydroxy-5-oxopyrrolidin-1-yl)ethoxy]-2-oxoethyl}-1,3-dihydroxypropylidene)amino]propyl}-2-hydroxy-5-oxopyrrolidine-2-carboxylic acid
12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione
12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione
(1s,8r,13s,14s,17s,26s)-12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione
(1s,8r,13s,14s,17s,26s)-12,13,25,26-tetrahydroxy-8,9,9-trimethyl-7-oxa-27,28,29-trithia-3,16,18-triazaoctacyclo[12.12.3.0¹,¹⁶.0³,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁷,²⁵.0¹⁹,²⁴]nonacosa-6(10),19,21,23-tetraene-2,11,15-trione
